- Home
- MNSB vs COYA Comparison
MNSB vs COYA Comparison
Compare MNSB & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNSB | COYA |
|---|---|---|
| Founded | 2003 | 2020 |
| Country | United States | United States |
| Employees | 204 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.4M | 126.6M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | MNSB | COYA |
|---|---|---|
| Price | $21.18 | $4.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | 61.3K | ★ 93.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,554,061.00 |
| Revenue This Year | $1.50 | $69.95 |
| Revenue Next Year | $3.77 | N/A |
| P/E Ratio | $12.64 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.00 | $3.94 |
| 52 Week High | $23.44 | $7.75 |
Technical Indicators
Market Signals| Indicator | MNSB | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | 46.87 |
| Support Level | $20.88 | $4.50 |
| Resistance Level | $22.13 | $5.21 |
| Average True Range (ATR) | 0.60 | 0.25 |
| MACD | -0.15 | 0.01 |
| Stochastic Oscillator | 37.91 | 31.73 |
Price Performance
Historical ComparisonAbout MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.